Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07RKN
|
|||
Former ID |
DNCL002214
|
|||
Drug Name |
GGTI-2418
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
Company |
Kirax
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H31N5O4
|
|||
Canonical SMILES |
CC1=C(N=CN1)CN2CCN(C(C2=O)CC3=CC=CC=C3)C(=O)NC(CC(C)C)C(=O)O
|
|||
InChI |
1S/C23H31N5O4/c1-15(2)11-18(22(30)31)26-23(32)28-10-9-27(13-19-16(3)24-14-25-19)21(29)20(28)12-17-7-5-4-6-8-17/h4-8,14-15,18,20H,9-13H2,1-3H3,(H,24,25)(H,26,32)(H,30,31)/t18-,20-/m0/s1
|
|||
InChIKey |
COLCNDRDBCLVOC-ICSRJNTNSA-N
|
|||
CAS Number |
CAS 501010-06-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Farnesyl protein transferase (Ftase) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030147) | |||
REF 2 | Company report (Prescient) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.